arrow
M

Matthias Gautschi

University of Bern
H指数:28
被引数:4,166

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bi-allelic variants in NDUFA5 cause a mitochondriopathy with complex I deficiency

NDUFA5基因的双等位基因变异导致伴有复合体I缺乏的线粒体病

2026-03-300
OA
Heterozygous loss of SRRM1 may be associated with neurodevelopmental phenotypes and anomalies in cell growth and neurite morphology

杂合性SRRM1缺失可能与神经发育表型以及细胞生长和神经突形态异常相关。

2025-10-270
OA
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial

Arimoclomol在尼曼-皮克病C型中的长期疗效与安全性:NPC-002 48个月开放标签扩展试验2/3期的最终结果

2025-07-070
PRE
Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b

依帕列净治疗21例糖原贮积病1b婴儿的中性粒细胞减少和中性粒细胞功能障碍

2024-06-011
OAAI
Trial of N-Acetyl-L-Leucine in Niemann-Pick Disease Type C
2024-02-018
PRE
Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-Pick disease type C
2024-02-010
PRE
Galactose epimerase deficiency: lessons from the GalNet registry
2022-09-022
OAAI
Persistent effect of arimoclomol in patients with Niemann-Pick disease type C: 24-month results from an open-label extension of a pivotal phase 2/3 study

arimoclomol对C型niemann-pick病患者的持续作用: 关键2/3期研究的开放标签扩展的24个月结果

2022-02-010
PRE
Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study (vol 15, 328, 2020)
2021-06-011
OAAI
Persistent effect of arimoclomol in patients with Nuemann-Pick disease type C: 12-month results from an open-label extension of a pivotal phase 2/3 study
2021-02-010
PREAI